Skip to content

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

About Us
Our Science
Media
Pipeline
- Overview
- AWARE-1
- BRACELET-1
- GOBLET
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs
Careers
Contact

News

Select Year
Clinical Trials
Search …

July 6, 2011

Oncolytics Biotech® Inc. Collaborators Present Positive REOLYSIN® Clinical Trial Results at the 14th World Conference on Lung Cancer

July 5, 2011

Oncolytics Biotech Announces Appointment of Dr. George M. Gill as Chief Medical Officer

June 8, 2011

Oncolytics Biotech® Inc. Collaborators to Present Reovirus Research at the 14th World Conference on Lung Cancer

June 2, 2011

MEDIA ADVISORY – Oncolytics Biotech® Inc. to Present at Jeffries 2011 Global Healthcare Conference

May 12, 2011

Oncolytics Biotech® Inc. Announces First Quarter 2011 Results

May 12, 2011

Oncolytics Biotech® Inc. Reports Correction to First Quarter 2011 Results Press Release

May 11, 2011

Oncolytics Biotech® Inc. Enters into Commercial Supply Agreement with SAFC®

May 10, 2011

Oncolytics Biotech® Inc. Announces Phase I Multiple Myeloma Cancer Study

May 5, 2011

Oncolytics Biotech® Inc. Announces Details of 2011 Annual Shareholder Meeting

April 20, 2011

Oncolytics Biotech® Inc. Announces Positive Data from Translational Clinical Trial Investigating REOLYSIN® in Patients with Metastatic Colorectal Cancer

Page 49 of 69

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.ca

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Loading...

4350 Executive Drive
Suite 325
San Diego, CA 92121
info@oncolyticsbiotech.com

Company

About Us
Leadership
Scientific Advisors
Careers
Contact

Science

Our Science
Pipeline
Publications

Investors

Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs

Privacy Policy Accessibility Cookie Policy Disclaimer Sitemap Manage Consent

Copyright © 2025 Oncolytics Biotech Inc.